Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Fake HIV Medications
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Poisonous cough syrup
    • Counterfeit Pill Crisis
  • Patients
    • About Counterfeits / Save Money Safely
    • Talk to Your Family
    • HIV/HEPC Patients
    • Med spas
    • Mexican Pharmacies
    • Drug importation
  • Professionals
    • Pharmacists
    • Doctors
    • Law Enforcement
    • Prosecution Document Library
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Med spas
    • Drug Importation
    • Illegal Pill Presses
    • PBM under-reimbursement
    • FOIA-ed Materials
    • Events, briefings, and op-eds
  • About Us
    • Join Our Mailing List
    • Members
    • PSM Leadership
    • Press Releases
    • Contact Us
Document Tags: 3:24-cv-00667, Complaint, GLP-1 lawsuit, Novo Nordisk, Tennessee, compounding, midtown express, semaglutide
Return to list

United States District Court
Middle District of Tennessee, Nashville Division

Novo Nordisk Inc. v. Dunklau Pharmacy Holdings, LLC, dba Midtown Express Pharmacy, etc

Complaint

May 30, 2024

Read the document.

<a href="https://www.safemedicines.org/wp-content/uploads/2019/09/Novo-Nordisk-v-MidtownExpress-Complaint.pdf">Novo Nordisk v Midtown Express Pharmacy</a><br>Filed in Tennessee, May 30, 2024
© 2003-2026 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top